Takeda Pharmaceutical Q1 EPS $0.40 Down From $0.56 YoY, Sales $7.33B Down From $7.51B YoY
Portfolio Pulse from Benzinga Newsdesk
Takeda Pharmaceutical (NYSE:TAK) reported a decrease in Q1 earnings and sales YoY. Earnings per share fell by 28.57% to $0.40 from $0.56, and sales dropped by 2.37% to $7.33 billion from $7.51 billion.
July 27, 2023 | 7:09 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Takeda Pharmaceutical's Q1 earnings and sales have decreased YoY, which could negatively impact the stock price in the short term.
Takeda Pharmaceutical's Q1 earnings and sales have decreased compared to the same period last year. This underperformance could lead to a decrease in investor confidence, potentially driving the stock price down in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100